MENU
BMEA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Biomea Fusion (BMEA) Ownership - Who owns Biomea Fusion?
Biomea Fusion Inc is a clinical-stage diabetes and obesity medicines company focused on the discovery and development of oral covalent small-molecule drugs to treat patients with metabolic diseases... Show more
Profile
Industry
N/A
Address
900 Middlefield Road
Phone
+1 650 980-9099
Employees
103
Web
https://www.biomeafusion.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
86.42M
P/E Ratio
N/A
Total Cash
87.95M
Projected Growth
N/A
Total Debt
9.57M
Revenue
N/A
Risk (Beta)
0.14
Dividend Yield
N/A
Total Cash/Share
2.34
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
BMEA
Capitalization
86.4M
P/E Ratio
N/A
Risk (Beta)
0.14
Dividend Yield
N/A
Total Cash
88M
Total Cash/Share
2.34
Total Debt
9.57M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
76M
P/B Ratio
1.68
Cash Flow
N/A
Earnings
-4.01
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
4K
Current Ratio
3.39
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-149.62M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-85.85
Shares Held By Institutions
124M
Shares Outstanding - Current
37.6M
Total Liabilities
34.4M
Total Volume MTD
N/A
Value
1
Gain YTD
-40.722
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
900 Middlefield Road
Phone
+1 650 980-9099
Employees
103
Web
https://www.biomeafusion.com